Nelson Fernandes, CerTest Biotec, on Diagnostic Products
We caught up with Nelson Fernandes, the Managing Director at CerTest Biotec, at 33rd ECCMID as he discusses his company’s diagnostic and molecular biology products. He explains that CerTest Biotec specializes in the development of rapid diagnostic tests for infectious diseases, including COVID-19.
Fernandes highlights some of the company’s other key products, such as CerTec’s raw materials and Pharma products.
- Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration Read more
- Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease Read more
- Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas Read more
- Quell Therapeutics Signs Agreement with AstraZeneca to Develop and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Read more
- Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430 Read more